637 related articles for article (PubMed ID: 28408007)
1. Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores.
McClure NS; Sayah FA; Xie F; Luo N; Johnson JA
Value Health; 2017 Apr; 20(4):644-650. PubMed ID: 28408007
[TBL] [Abstract][Full Text] [Related]
2. Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols.
Henry EB; Barry LE; Hobbins AP; McClure NS; O'Neill C
Value Health; 2020 Jul; 23(7):936-944. PubMed ID: 32762996
[TBL] [Abstract][Full Text] [Related]
3. Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes.
McClure NS; Sayah FA; Ohinmaa A; Johnson JA
Value Health; 2018 Sep; 21(9):1090-1097. PubMed ID: 30224114
[TBL] [Abstract][Full Text] [Related]
4. Estimating an EQ-5D-5L Value Set for China.
Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Internal Structure of the EQ-5D Using Non-Preference-Based Methods.
Feng YS; Jiang R; Kohlmann T; Pickard AS
Value Health; 2019 May; 22(5):527-536. PubMed ID: 31104730
[TBL] [Abstract][Full Text] [Related]
7. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in elderly people with hypertension and the estimation of minimally important difference using EQ-5D-5L in Hong Kong SAR, China.
Wong ELY; Xu RH; Cheung AWL
Eur J Health Econ; 2020 Aug; 21(6):869-879. PubMed ID: 32242296
[TBL] [Abstract][Full Text] [Related]
9. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.
Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
Value Health; 2019 Jan; 22(1):38-44. PubMed ID: 30661632
[TBL] [Abstract][Full Text] [Related]
10. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
11. Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets.
Lamu AN; Chen G; Gamst-Klaussen T; Olsen JA
Qual Life Res; 2018 Jul; 27(7):1801-1814. PubMed ID: 29569014
[TBL] [Abstract][Full Text] [Related]
12. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
[TBL] [Abstract][Full Text] [Related]
14. An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care.
Ratcliffe J; Flint T; Easton T; Killington M; Cameron I; Davies O; Whitehead C; Kurrle S; Miller M; Liu E; Crotty M
Appl Health Econ Health Policy; 2017 Jun; 15(3):399-412. PubMed ID: 27882528
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
Yang F; Devlin N; Luo N
Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
[TBL] [Abstract][Full Text] [Related]
16. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
[TBL] [Abstract][Full Text] [Related]
18. How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence.
Yang Z; Feng Z; Busschbach J; Stolk E; Luo N
Value Health; 2019 Jul; 22(7):829-836. PubMed ID: 31277831
[TBL] [Abstract][Full Text] [Related]
19. Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results.
Gerlinger C; Bamber L; Leverkus F; Schwenke C; Haberland C; Schmidt G; Endrikat J
BMC Res Notes; 2019 Jan; 12(1):18. PubMed ID: 30642397
[TBL] [Abstract][Full Text] [Related]
20. Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients.
Siriwardana AN; Hoffman AT; Morton RL; Smyth B; Brown MA
Value Health; 2024 Apr; 27(4):469-477. PubMed ID: 38307389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
